{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:25:52Z","timestamp":1793985952955,"version":"4.8.0"},"reference-count":80,"publisher":"Bioscientifica","issue":"11","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Differentiated thyroid cancer (DTC) is characterized by retention of thyroid-specific functions, particularly iodide uptake mediated by the sodium\u2013iodide symporter (NIS), which underlies the effectiveness of radioiodine (RAI) imaging and therapy. Loss of iodine avidity reflects tumor dedifferentiation and is a defining feature of aggressive, RAI-refractory disease. The thyroid differentiation score (TDS), introduced by The Cancer Genome Atlas (TCGA) program, provides a quantitative transcriptomic measure of thyroid lineage identity based on coordinated expression of genes involved in thyroid hormone biosynthesis and transport. This comprehensive narrative review synthesizes current evidence supporting TDS as a unifying framework linking oncogenic drivers, signaling pathways, the tumor microenvironment, metabolic reprogramming, and clinical behavior across thyroid cancer subtypes, including papillary, follicular, poorly differentiated, anaplastic, and pediatric tumors. MAPK pathway activation, particularly via BRAFV600E, is associated with suppression of thyroid differentiation programs, whereas RAS-like and fusion-driven tumors tend to retain higher differentiation states. Emerging data connect TDS with tumor aggressiveness, recurrence risk, immune and inflammatory signaling, and resistance to RAI therapy. The role of TDS in guiding redifferentiation strategies using targeted tyrosine kinase inhibitors is also discussed, highlighting its potential as a biomarker for patient selection in RAI resensitization approaches. TDS is a well-established biological measure of thyroid-lineage differentiation and has shown prognostic associations in retrospective studies. However, its value as an individual predictive or theranostic biomarker remains investigational. Future work should focus on developing a personalized theranostic TDS that integrates matched normal tissue, molecular profiling, functional imaging, and machine learning to potentially better predict iodine-handling capacity and optimize precision management in thyroid cancer.<\/jats:p>","DOI":"10.1530\/erc-26-0333","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:03:58Z","timestamp":1792577038000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Thyroid differentiation score as a molecular bridge between genotype, tumor biology, and radioiodine theranostics in thyroid cancer"],"prefix":"10.1530","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3714-4676","authenticated-orcid":true,"given":"Anthony J","family":"McGoron","sequence":"first","affiliation":[{"name":"Florida International University, College of Engineering and Computing 1 , , ,","place":["Miami, Florida, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"2026110611470067300_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Cell"},{"key":"2026110611470067300_bib2","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1210\/jc.2009-0247","article-title":"Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules","volume":"94","author":"Nikiforov","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2026110611470067300_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf"},{"key":"2026110611470067300_bib4","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3390\/cimb44040101","article-title":"Propensity score-matched analysis to identify pathways associated with loss of sodium iodide symporter in papillary thyroid cancer","volume":"44","author":"Lee","year":"2022","journal-title":"Curr Issues Mol Biol"},{"key":"2026110611470067300_bib5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1210\/clinem\/dgab851","article-title":"Characterization of subtypes of BRAF-mutant papillary thyroid cancer defined by their thyroid differentiation score","volume":"107","author":"Boucai","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026110611470067300_bib6","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1158\/1078-0432.CCR-22-2882","article-title":"Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy","volume":"29","author":"Boucai","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2026110611470067300_bib7","article-title":"Thyroid differentiation score discordance in BRAF-like papillary thyroid carcinoma: clinicopathologic associations and progression-free interval in TCGA-THCA","author":"Allen","year":"2026","journal-title":"Research Square"},{"key":"2026110611470067300_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3835(03)00392-6","article-title":"Low expression of sodium iodide symporter identifies aggressive thyroid tumors","volume":"200","author":"Ward","year":"2003","journal-title":"Cancer Lett"},{"key":"2026110611470067300_bib9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s10147-013-0620-z","article-title":"Low expression of sodium iodide symporter expression in aggressive variants of papillary thyroid carcinoma","volume":"19","author":"Wei","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"2026110611470067300_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1530\/EC-17-0302","article-title":"NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features","volume":"7","author":"Tavares","year":"2018","journal-title":"Endocr Connect"},{"key":"2026110611470067300_bib11","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.7150\/thno.57689","article-title":"Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS","volume":"11","author":"Oh","year":"2021","journal-title":"Theranostics"},{"key":"2026110611470067300_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/cncr.22754","article-title":"Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis","volume":"110","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"2026110611470067300_bib13","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1210\/jc.2006-2707","article-title":"BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism","volume":"92","author":"Durante","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2026110611470067300_bib14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1677\/ERC-07-0130","article-title":"BRAFV600E mutation, but not RET\/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer","volume":"15","author":"Romei","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"2026110611470067300_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/ERC-13-0399","article-title":"Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer","volume":"21","author":"Zhang","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"2026110611470067300_bib16","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1078-0432.CCR-06-1753","article-title":"Suppression of BRAF\/MEK\/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant","volume":"13","author":"Liu","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2026110611470067300_bib17","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1172\/JCI46382","article-title":"Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation","volume":"121","author":"Chakravarty","year":"2011","journal-title":"J Clin Investig"},{"key":"2026110611470067300_bib18","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1172\/JCI89067","article-title":"Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine","volume":"126","author":"Nagarajah","year":"2016","journal-title":"J Clin Investig"},{"key":"2026110611470067300_bib19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1530\/EC-19-0045","article-title":"Clinical significance of the BRAFV600E mutation in PTC and its effect on radioiodine therapy","volume":"8","author":"Zhu","year":"2019","journal-title":"Endocr Connect"},{"key":"2026110611470067300_bib20","doi-asserted-by":"crossref","first-page":"1665545","DOI":"10.3389\/fendo.2025.1665545","article-title":"The effect of BRAFV600E mutation on radioiodine therapy in patients with papillary thyroid carcinoma: a meta-analysis and systematic review","volume":"16","author":"Wang","year":"2025","journal-title":"Front Endocrinol"},{"key":"2026110611470067300_bib21","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-25-0167","article-title":"Clinical relevance of the thyroid differentiation score (TDS) in benign and malignant thyroid tumors","volume":"32","author":"Muzza","year":"2025","journal-title":"Endocr Relat Cancer"},{"key":"2026110611470067300_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/clinem\/dgae532","article-title":"The association between thyroid differentiation score and survival outcomes in papillary thyroid carcinoma","volume":"110","author":"Wang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026110611470067300_bib23","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.surg.2016.12.039","article-title":"Recurrence-associated genes in papillary thyroid cancer: an analysis of data from The Cancer Genome Atlas","volume":"161","author":"Chien","year":"2017","journal-title":"Surgery"},{"key":"2026110611470067300_bib24","article-title":"Thyroid differentiation profile for differentiated thyroid cancer","volume":"5","author":"McGoron","year":"2025","journal-title":"Endocr Oncol"},{"key":"2026110611470067300_bib25","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-18-2953","article-title":"Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies","volume":"25","author":"Landa","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026110611470067300_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ohn.70298","article-title":"The molecular heterogeneity of NRAS variants in thyroid nodules","volume":"175","author":"Ravin","year":"2026","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2026110611470067300_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13046-020-01757-x","article-title":"The molecular and gene\/miRNA expression profiles of radioiodine resistant papillary thyroid cancer","volume":"39","author":"Colombo","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"2026110611470067300_bib28","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/cancers12061597","article-title":"TERT promoter mutations and their impact on gene expression profile in papillary thyroid carcinoma","volume":"12","author":"Rusinek","year":"2020","journal-title":"Cancers"},{"key":"2026110611470067300_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.11106\/ijt.2018.11.2.152","article-title":"Expression of sodium-iodide symporter depending on mutational status and lymphocytic thyroiditis in papillary thyroid carcinoma","volume":"11","author":"Song","year":"2018","journal-title":"Int J Thyroidology"},{"key":"2026110611470067300_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156112","article-title":"Clinicopathological and molecular characteristics of papillary thyroid carcinoma with BRAF V600E and TERT promoter co-mutations","volume":"272","author":"Liu","year":"2025","journal-title":"Pathol Res Pract"},{"key":"2026110611470067300_bib31","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1089\/thy.2019.0065","article-title":"Characterization of activating mutations of the MEK1 gene in papillary thyroid carcinomas","volume":"29","author":"Borrelli","year":"2019","journal-title":"Thyroid"},{"key":"2026110611470067300_bib32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1530\/EC-21-0135","article-title":"SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer","volume":"10","author":"Jin","year":"2021","journal-title":"Endocr Connections"},{"key":"2026110611470067300_bib33","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41467-024-45366-0","article-title":"Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses","volume":"15","author":"Lee","year":"2024","journal-title":"Nat Commun"},{"key":"2026110611470067300_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s12276-022-00740-0","article-title":"Dissection of molecular and histological subtypes of papillary thyroid cancer using alternative splicing profiles","volume":"54","author":"Park","year":"2022","journal-title":"Exp Mol Med"},{"key":"2026110611470067300_bib35","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.3390\/cancers13205184","article-title":"Molecular signature expands the landscape of driver negative thyroid cancers","volume":"13","author":"Bim","year":"2021","journal-title":"Cancers"},{"key":"2026110611470067300_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/clinem\/dgad458","article-title":"Nodal metastases associated with fusion oncogenes are age dependent in young adult patients with thyroid cancer","volume":"109","author":"Li","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026110611470067300_bib37","doi-asserted-by":"crossref","first-page":"10607","DOI":"10.18632\/aging.205100","article-title":"TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer","volume":"15","author":"Ma","year":"2023","journal-title":"Aging Us"},{"key":"2026110611470067300_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00418-026-02480-y","article-title":"Oncogenic overexpression of kallikrein-related peptidase 7 is associated with the progression of thyroid cancer","volume":"164","author":"Chi","year":"2026","journal-title":"Histochem Cell Biol"},{"key":"2026110611470067300_bib39","article-title":"Aberrant expression of COT is related to recurrence of papillary thyroid cancer","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine"},{"key":"2026110611470067300_bib40","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.21037\/tcr-2025-460","article-title":"Thyroid differentiation score-related genes and prognostic model for thyroid cancer","volume":"14","author":"Lin","year":"2025","journal-title":"Transl Cancer Res"},{"key":"2026110611470067300_bib41","article-title":"Identification of risk factors for high-risk dedifferentiation in papillary thyroid carcinoma and construction of discriminative model","volume":"15","author":"Liu","year":"2025","journal-title":"Front Oncol"},{"key":"2026110611470067300_bib42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12672-025-02079-0","article-title":"Bioinformatic analysis of serpina1 expression in papillary thyroid carcinoma and its potential association with Hashimoto\u2019s thyroiditis","volume":"16","author":"Du","year":"2025","journal-title":"Discov Oncol"},{"key":"2026110611470067300_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/ancp\/8843563","article-title":"BRAF mutation affects intratumor heterogeneity in papillary thyroid carcinoma","volume":"2026","author":"Feng","year":"2026","journal-title":"Anal Cell Pathol"},{"key":"2026110611470067300_bib44","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1210\/clinem\/dgae750","article-title":"Somatic-mutant benign thyroid nodules in adults: a group of follicular nodular disease with continuous growth","volume":"110","author":"Meng","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026110611470067300_bib45","article-title":"Identification of key functional gene signatures indicative of dedifferentiation in papillary thyroid cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"2026110611470067300_bib46","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest"},{"key":"2026110611470067300_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf3657","article-title":"Characterizing dedifferentiation of thyroid cancer by integrated analysis","volume":"7","author":"Luo","year":"2021","journal-title":"Sci Adv"},{"key":"2026110611470067300_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006239","article-title":"Comprehensive analysis of the transcriptional and mutational landscape of follicular and papillary thyroid cancers","volume":"12","author":"Yoo","year":"2016","journal-title":"PLoS Genet"},{"key":"2026110611470067300_bib49","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1089\/thy.2018.0198","article-title":"Comprehensive transcriptomic and genomic profiling of subtypes of follicular variant of papillary thyroid carcinoma","volume":"28","author":"Song","year":"2018","journal-title":"Thyroid"},{"key":"2026110611470067300_bib50","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-24-0207","article-title":"Reappraisal of BRAFK601E-positive thyroid tumors in the NIFTP era","volume":"31","author":"Doerfler","year":"2024","journal-title":"Endocr Relat Cancer"},{"key":"2026110611470067300_bib51","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1210\/jc.2014-3647","article-title":"Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years","volume":"100","author":"Lee","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026110611470067300_bib52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/ERC-20-0464","article-title":"Pan-genomic characterization of high-risk pediatric papillary thyroid carcinoma","volume":"28","author":"Stenman","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"2026110611470067300_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144847","article-title":"NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake","volume":"131","author":"Lee","year":"2021","journal-title":"J Clin Investig"},{"key":"2026110611470067300_bib54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12020-026-04588-6","article-title":"BRAF\/MEK inhibitors for redifferentiation in patients with radioiodine refractory thyroid cancer: a systematic review and meta-analysis","volume":"91","author":"Shi","year":"2026","journal-title":"Endocrine"},{"key":"2026110611470067300_bib55","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/jc.2018-01478","article-title":"Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers","volume":"104","author":"Dunn","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026110611470067300_bib56","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0227","article-title":"Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers","volume":"13","author":"Syed","year":"2024","journal-title":"Eur Thyroid J"},{"key":"2026110611470067300_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41419-020-03294-z","article-title":"A new risk factor indicator for papillary thyroid cancer based on immune infiltration","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis"},{"key":"2026110611470067300_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008505","article-title":"Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies","volume":"12","author":"Mohanty","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026110611470067300_bib59","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/ERC-17-0532","article-title":"Immune landscape of papillary thyroid cancer and immunotherapeutic implications","volume":"25","author":"Na","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2026110611470067300_bib60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12935-021-01939-3","article-title":"Identification of an immune-related signature indicating the dedifferentiation of thyroid cells","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int"},{"key":"2026110611470067300_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.21053\/ceo.2021.02215","article-title":"Transcriptomic analysis of papillary thyroid cancer: a focus on immune-subtyping, oncogenic fusion, and recurrence","volume":"15","author":"Park","year":"2022","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"2026110611470067300_bib62","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0110","article-title":"Papillary thyroid cancer immune phenotypes via tumor-infiltrating lymphocyte spatial analysis","volume":"30","author":"Nam","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"2026110611470067300_bib63","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1089\/thy.2017.0359","article-title":"Transcriptome network analysis reveals aging-related mitochondrial and proteasomal dysfunction and immune activation in human thyroid","volume":"28","author":"Cho","year":"2018","journal-title":"Thyroid"},{"key":"2026110611470067300_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154495","article-title":"Inflammatory tumor microenvironment of thyroid cancer promotes cellular dedifferentiation and silencing of iodide-handling genes expression","volume":"246","author":"Zhang","year":"2023","journal-title":"Pathol Res Pract"},{"key":"2026110611470067300_bib65","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/OTT.S294725","article-title":"Cancer-associated fibroblasts positively correlate with dedifferentiation and aggressiveness of thyroid cancer","volume":"14","author":"Wen","year":"2021","journal-title":"Onco Targets Ther"},{"key":"2026110611470067300_bib66","article-title":"GDF10 and IDO1 as a thyroid cancer prognostic biomarker associated with immune infiltration","volume":"10","author":"Lv","year":"2024","journal-title":"Heliyon"},{"key":"2026110611470067300_bib67","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0270","article-title":"TGFBR3 inhibits progression of papillary thyroid cancer by inhibiting the PI3K\/AKT pathway and EMT","volume":"13","author":"Zhang","year":"2024","journal-title":"Endocr Connections"},{"key":"2026110611470067300_bib68","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/thy.2024.0266","article-title":"Transcriptome of anaplastic thyroid cancer reveals two molecular subtypes with distinct tumor microenvironment and prognosis","volume":"35","author":"Byun","year":"2025","journal-title":"Thyroid"},{"key":"2026110611470067300_bib69","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00262-025-04210-0","article-title":"Tumor microenvironment remodeling across thyroid cancer differentiation states revealed by spatial transcriptomics","volume":"74","author":"Seok","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"2026110611470067300_bib70","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1186\/s12885-019-6482-7","article-title":"Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer","volume":"19","author":"Suh","year":"2019","journal-title":"BMC Cancer"},{"key":"2026110611470067300_bib71","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1089\/ars.2015.6616","article-title":"NADPH oxidase NOX4 is a critical mediator of BRAF(V600E)-Induced downregulation of the sodium\/iodide symporter in papillary thyroid carcinomas","volume":"26","author":"Azouzi","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"2026110611470067300_bib72","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.3390\/cancers14235857","article-title":"Oxidative stress correlates with more aggressive features in thyroid cancer","volume":"14","author":"Muzza","year":"2022","journal-title":"Cancers"},{"key":"2026110611470067300_bib73","first-page":"133","article-title":"Polarity reversal of inside-out thyroid follicles cultured within collagen gel: structure of the junctions assessed by freeze-fracture and lanthanum permeability","volume":"62","author":"Barriere","year":"1988","journal-title":"Biol Cell"},{"key":"2026110611470067300_bib74","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/endo-126-4-2027","article-title":"Reconstruction of thyroid follicles from isolated porcine follicle cells in three-dimensional collagen gel culture","volume":"126","author":"Toda","year":"1990","journal-title":"Endocrinology"},{"key":"2026110611470067300_bib75","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.stemcr.2021.02.011","article-title":"Generation and differentiation of adult tissue-derived human thyroid organoids","volume":"16","author":"Ogundipe","year":"2021","journal-title":"Stem Cell Rep"},{"key":"2026110611470067300_bib76","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117017118","article-title":"Adult mouse and human organoids derived from thyroid follicular cells and modeling of Graves\u2019 hyperthyroidism","volume":"118","author":"van der Vaart","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026110611470067300_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41388-023-02889-y","article-title":"Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids","volume":"43","author":"Lasolle","year":"2024","journal-title":"Oncogene"},{"key":"2026110611470067300_bib78","article-title":"Construction of thyroid cancer classification and iodine metabolism related diagnostic model using thyroid differentiation score and bioinformation","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine"},{"key":"2026110611470067300_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12902-025-01867-7","article-title":"Nomogram for predicting the risk of cervical lymph node metastases and recurrence in papillary thyroid carcinoma based on the thyroid differentiation score system and clinical characteristics","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"2026110611470067300_bib80","doi-asserted-by":"crossref","first-page":"19075","DOI":"10.1073\/pnas.0509603102","article-title":"The role of microRNA genes in papillary thyroid carcinoma","volume":"102","author":"He","year":"2005","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0333\/526752\/erc-26-0333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0333\/526752\/erc-26-0333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:47:16Z","timestamp":1793983636000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/11\/e260333\/78403\/Thyroid-differentiation-score-as-a-molecular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-26-0333","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"article-number":"e260333"}}